{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:52:59Z","timestamp":1760575979371,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[1999,6]]},"DOI":"10.1053\/clon.1999.9036","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T09:54:50Z","timestamp":1032429290000},"page":"174-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Pilot Study of Continuous Infusional 5-Fluorouracil, Doxorubicin and Cyclophosphamide in Breast Cancer"],"prefix":"10.1053","volume":"11","author":[{"given":"H.J.","family":"Mackay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bissett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Twelves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.A.","family":"Vasey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/clon.1999.9036_RF1","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/jnci\/82.19.1539","article-title":"Primary chemotherapy to avoid mastectomy in tumours with diameters of three centimeters or more","volume":"82","author":"Bonadonna","year":"1990","journal-title":"J Natl Cancer Inst"},{"year":"1991","series-title":"Medical management of breast cancer","author":"Powles","key":"10.1053\/clon.1999.9036_RF2"},{"key":"10.1053\/clon.1999.9036_RF3","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/1097-0142(19811215)48:12<2565::AID-CNCR2820481204>3.0.CO;2-E","article-title":"Phase I study of protracted venous infusion of 5-fluorouracil","volume":"48","author":"Lokich","year":"1981","journal-title":"Cancer"},{"key":"10.1053\/clon.1999.9036_RF4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0305-7372(94)90017-5","article-title":"Infusional 5-fluorouracil in breast cancer","volume":"20","author":"Ng","year":"1994","journal-title":"Cancer Treat Rev"},{"key":"10.1053\/clon.1999.9036_RF5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0936-6555(05)80661-2","article-title":"Successful thrombolysis of SVC thrombosis associated with Hickman lines and continuous infusion chemotherapy","volume":"8","author":"Bissett","year":"1996","journal-title":"Clin Oncol"},{"key":"10.1053\/clon.1999.9036_RF6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/bjc.1977.42","article-title":"Assessment of response to therapy in advanced breast cancer","volume":"35","author":"Hayward","year":"1977","journal-title":"Br J Cancer"},{"key":"10.1053\/clon.1999.9036_RF7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/bjc.1978.182","article-title":"Assessment of response to therapy in advanced breast cancer (an amendment)","volume":"38","author":"Hayward","year":"1977","journal-title":"Br J Cancer"},{"key":"10.1053\/clon.1999.9036_RF8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/bjc.1957.43","article-title":"Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed 15 years","volume":"11","author":"Bloom","year":"1957","journal-title":"Br J Cancer"},{"key":"10.1053\/clon.1999.9036_RF9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.1995.13.3.547","article-title":"Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer","volume":"13","author":"Powles","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1053\/clon.1999.9036_RF10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0959-8049(94)90537-1","article-title":"Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6","volume":"30A","author":"Scholl","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1053\/clon.1999.9036_RF11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1200\/JCO.1995.13.2.424","article-title":"High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer","volume":"13","author":"Smith","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1053\/clon.1999.9036_RF12","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1038\/bjc.1996.668","article-title":"Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer","volume":"74","author":"Gabra","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1053\/clon.1999.9036_RF13","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1200\/JCO.1994.12.6.1259","article-title":"Phase II study of continuous infusion fluorouracil with epirubicin and cisplatinum in patients with metastatic and locally advanced breast cancer: An active regime","volume":"12","author":"Jones","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1053\/clon.1999.9036_RF14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/bjc.1996.67","article-title":"Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic\/locally advanced breast cancer (infusional ECarboF): a very active and well-tolerated outpatient regimen","volume":"73","author":"Bonnfoi","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1053\/clon.1999.9036_RF15","first-page":"227","article-title":"Tumour selectivity of XelodaTM in colorectal cancer patients","volume":"16","author":"Schueller","year":"1997","journal-title":"Proc ASCO"},{"key":"10.1053\/clon.1999.9036_RF16","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1200\/JCO.1994.12.11.2296","article-title":"Phase II trial of Uracil and Tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma","volume":"12","author":"Pazdur","year":"1994","journal-title":"J Clin Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655599990362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655599990362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:22:29Z","timestamp":1760541749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655599990362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,6]]}},"alternative-id":["S0936655599990362"],"URL":"https:\/\/doi.org\/10.1053\/clon.1999.9036","relation":{},"ISSN":["0936-6555"],"issn-type":[{"type":"print","value":"0936-6555"}],"subject":[],"published":{"date-parts":[[1999,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Pilot Study of Continuous Infusional 5-Fluorouracil, Doxorubicin and Cyclophosphamide in Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/clon.1999.9036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1999 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}